Pfizer to launch Lyrica DTC

Share this article:
Pfizer plans to launch DTC promoting Lyrica for fibromyalgia in the fall, just five months after gaining approval for the condition under its "fast to market" strategy, the Pink Sheet reports.  

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.